Brian Concannon, President & CEO at HAEMONETICS CORP (HAE), sold 6,569 shares at $42.51 ($279K) on 2015-06-15, disclosed to the SEC on 2015-06-17.
Scheduled sale ($279k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNMD | SELL | 2022-02-04 | $2.9M | — | Filing → |
| CNMD | SELL | 2020-09-14 | $542K | — | Filing → |
| HAE | SELL | 2015-09-16 | $231K | — | Filing → |